11.10
前日終値:
$11.14
開ける:
$11.14
24時間の取引高:
464.67K
Relative Volume:
0.46
時価総額:
$1.06B
収益:
$174.54M
当期純損益:
$6.03M
株価収益率:
138.75
EPS:
0.08
ネットキャッシュフロー:
$15.96M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-1.94%
6か月 パフォーマンス:
+17.21%
1年 パフォーマンス:
+20.00%
Enfusion Inc Stock (ENFN) Company Profile
名前
Enfusion Inc
セクター
電話
(312) 253-9800
住所
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
ENFN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ENFN
Enfusion Inc
|
11.10 | 1.06B | 174.54M | 6.03M | 15.96M | 0.08 |
![]()
SAP
Sap Se Adr
|
268.00 | 312.62B | 36.97B | 3.37B | 4.79B | 2.8498 |
![]()
CRM
Salesforce Inc
|
269.97 | 266.98B | 37.90B | 6.20B | 12.43B | 6.36 |
![]()
INTU
Intuit Inc
|
598.92 | 172.01B | 17.17B | 3.04B | 5.63B | 10.72 |
![]()
NOW
Servicenow Inc
|
797.76 | 170.92B | 10.98B | 1.43B | 3.38B | 6.83 |
![]()
ADBE
Adobe Inc
|
385.71 | 164.39B | 22.04B | 6.75B | 9.19B | 15.18 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-10 | 再開されました | Morgan Stanley | Overweight |
2024-02-28 | ダウングレード | Goldman | Neutral → Sell |
2024-01-30 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-11-07 | 開始されました | UBS | Neutral |
2023-04-03 | 開始されました | Piper Sandler | Neutral |
2023-03-15 | 開始されました | JP Morgan | Neutral |
2023-01-04 | ダウングレード | BofA Securities | Neutral → Underperform |
2023-01-03 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-10-03 | ダウングレード | BofA Securities | Buy → Neutral |
2021-11-15 | 開始されました | BofA Securities | Buy |
2021-11-15 | 開始されました | Credit Suisse | Neutral |
2021-11-15 | 開始されました | Goldman | Neutral |
2021-11-15 | 開始されました | Morgan Stanley | Equal-Weight |
2021-11-15 | 開始されました | Piper Sandler | Overweight |
2021-11-15 | 開始されました | Stifel | Buy |
2021-11-15 | 開始されました | William Blair | Outperform |
すべてを表示
Enfusion Inc (ENFN) 最新ニュース
Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
(ENFN) Trading Report - Stock Traders Daily
Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN
Enfusion (ENFN) to Release Earnings on Tuesday - Defense World
Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa
Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India
Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada
Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada
Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com
Enfusion chief accounting officer sells $6,165 in stock - Investing.com
Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa
Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView
Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks
Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks
Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa
Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India
Enfusion Executives Unload Major Stock Holdings! - TipRanks
Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada
Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia
Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa
Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada
Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa
Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India
Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa
Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada
Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India
Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN
Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com
Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView
Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com
Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Adjusted EPS $0.03, vs. FactSet Est of $0.06 - Marketscreener.com
ATTENTION ENFN SHAREHOLDERS: Investors who lost money on Enfusion, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
Clearwater Analytics Awaits Enfusion Acquisition Completion - TipRanks
Fintech Merger Advances: Clearwater-Enfusion Deal Passes Key Regulatory TestWhat's Next? - StockTitan
Objective long/short (ENFN) Report - Stock Traders Daily
Enfusion Inc (ENFN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):